Aktieanalys

Lipigon: Positive Results in Phase I SAD - Redeye

{newsItem.title}

Redeye Publicerad: 05 Oct 2022 13:35

Lipigon Pharmaceuticals

Redeye comments on the positive results reported by Lipigon in the first part of the phase I study with Lipisense and updates its Base Case.

Länk till analysen i sin helhet: https://www.redeye.se/research/857139/lipigon-positive-results-in-phase-i-sad?utm_source=finwire&utm_medium=RSS

Nyheter om Lipigon Pharmaceuticals

Läses av andra just nu

Om aktien Lipigon Pharmaceuticals

Senaste nytt